Decision tool for mastectomy choices in new breast cancer
Part of Cancer clinical trials.
This study tests a decision-making tool to help people with newly diagnosed breast cancer make choices about removing the other (opposite) breast as a preventive step. It may help you think through risks and options in a clearer, more structured way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of breast cancer in one breast, such as DCIS or stage I–III invasive cancer
- Your cancer is in only one breast (not both)
- You can read, write, or speak English
- You have never had breast cancer before
- You have not already had a preventive mastectomy on both sides
- You do not have a known high-risk genetic mutation (like BRCA1/2) and are not considered very high risk for the other side based on family history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a patient-and-caregiver decision guide to help you decide when to start or stop a new cancer drug, join a clinical trial, or continue active surveillance. It aims to make tough choices feel clearer and more supported.
This study is testing a new tool to help women with early-stage breast cancer decide between lumpectomy (removing just the tumor) or mastectomy (removing the entire breast). The tool is designed for women who have not yet talked to a surgeon about their options.
This trial is testing a decision aid to help women newly diagnosed with breast cancer choose between different surgery options. It looks at how well this tool supports you in making a choice that fits your values and preferences.
This study is testing a decision tool to help people who are thinking about breast reconstruction surgery after a mastectomy. The tool is designed to help you and your doctor make a more informed choice.
This study tests a digital tool designed to help patients with advanced (stage IV) breast cancer make treatment decisions. The tool may help you understand your options and feel more confident discussing them with your doctor.
This study tests a tool called BREASTChoice AIM1-B, which helps people who have had breast surgery make informed choices about their follow-up care. You may be eligible if you had a mastectomy or lumpectomy in the past 8 years for breast cancer or to lower your risk.
Hear when a new Anatomic Stage I Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.